Filana Therapeutics/$FLNA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Filana Therapeutics

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Ticker
$FLNA
Sector
Health
Primary listing
NASDAQ
Employees
19
Headquarters
Austin, United States
Website
www.filanatx.com

FLNA Metrics

BasicAdvanced
$46m
-
-$0.88
-0.69
-

What the Analysts think about FLNA

Analyst ratings (Buy, Hold, Sell) for Filana Therapeutics stock.

FLNA Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

FLNA Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.